ZEB1 and brain cancer: Collectively, to our best knowledge, this is the first study showing that lncRNA ZEB1-AS1 is highly expressed in glioma tissues and its overexpression may be indicative of higher risks for brain cancer progression and poor overall survival rate, thereby suggesting its usage as an underlying prognostic marker and a new potential therapeutic target for the treatment of human gliomas.